✦ LIBER ✦

Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies

✍ Scribed by T. Said; M.R.N. Nampoory; K.V. Johny; A.S. Pacsa; P. Mini Abraham; M.P. Nair; M. Abdel-Haleem; M. Samhan; M. Al-Mousawi

Book ID: 116930139
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 64 KB
Volume: 36
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2004.07.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylaxis of cytomegalovirus disease w

Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy

✍ E Morales; A Andrés; E González; J.C Herrero; M.A Muñoz; M Ortiz; B Espejo; C Lu 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Cytomegalovirus disease in adult marrow

Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study

✍ Maltazou, H; Whimbey, E; Abi-Said, D; Przepiorka, D; Champlain, R; Goodrich, J M 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB

Ganciclovir prophylaxis for cytomegalovi

Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone

✍ A Lo; R.J Stratta; M.F Egidi; A.T Kizilisik; M.H Shokouh-Amiri; H.P Grewal; J Tr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Preemptive Therapy Versus Valgancyclovir

Preemptive Therapy Versus Valgancyclovir Prophylaxis in Cytomegalovirus-positive Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction

✍ Couzi, L.; Helou, S.; Bachelet, T.; Martin, S.; Moreau, K.; Morel, D.; Lafon, M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Increased incidence of cytomegalovirus i

Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis

✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos

Long-term outcome of cytomegalovirus inf

Long-term outcome of cytomegalovirus infection in simultaneous pancreas–kidney transplant recipients without ganciclovir prophylaxis

✍ Nada Rayes; Daniel Seehofer; Andreas Kahl; Sophia Kokott; Johann Pratschke; Ulri 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 224 KB